Literature DB >> 7734783

Mineral balance and whole body bone mineral content in very low-birth-weight infants.

A A Lapillonne1, F H Glorieux, B L Salle, P M Braillon, M Chambon, J Rigo, G Putet, J Senterre.   

Abstract

Fat and mineral metabolic balance studies were performed in 25 normal very low-birth-weight infants (< or = 1500 g at birth) fed either pooled pasteurized human milk supplemented with calcium, phosphorus and magnesium, or a preterm formula. Calcium, phosphorus and magnesium intake were similar in both groups and averaged 100 mg/kg/day, 72 mg/kg/day and 8 mg/kg/day, respectively. Calcium and phosphorus retention was higher in the subjects fed fortified human milk than in those receiving a preterm formula (65 +/- 14 and 62 +/- 9 mg/kg/day versus 55 +/- 12 and 47 +/- 7 mg/kg/day respectively). The difference was only significant for phosphorus. Magnesium retention was similar in the two groups and averaged 3 mg/kg/day. Fat intake and absorption was significantly higher in the preterm formula fed group than in the one fed fortified human milk (5.5 +/- 0.4 g/kg/day and 88 +/- 4% versus 4.2 +/- 1 g/kg/day, 79 +/- 6% respectively). Assessment of the whole body bone mineral content by dual energy X-ray absorptiometry was performed at 3 and 6 months of age in another group of 25 low-birth-weight infants fed either fortified human milk or a preterm formula. Whole body bone mineral content (BMCt) was low (43.3 +/- 30.8 g of hydroxyapatite) at 3 months of age (theoretical term) compared to normal full-term newborns at birth. There was no significant influence of the diet. At 6 months of age, BMCt reached 168.6 +/- 36.6 g, a value similar to that of full-term newborns, with no significant difference between the two regimen groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734783     DOI: 10.1111/j.1651-2227.1994.tb13409.x

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  7 in total

Review 1.  Skeletal development in premature infants: a review of bone physiology beyond nutritional aspects.

Authors:  F Rauch; E Schoenau
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

Review 2.  Nutritional aspects of metabolic bone disease in the newborn.

Authors:  S Ryan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

Review 3.  Fetal Physiologically Based Pharmacokinetic Models: Systems Information on the Growth and Composition of Fetal Organs.

Authors:  Khaled Abduljalil; Masoud Jamei; Trevor N Johnson
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 4.  Update on Calcium and Phosphorus Requirements of Preterm Infants and Recommendations for Enteral Mineral Intake.

Authors:  Walter Mihatsch; Ulrich Thome; Miguel Saenz de Pipaon
Journal:  Nutrients       Date:  2021-04-27       Impact factor: 5.717

5.  Changes in Biochemical Parameters of the Calcium-Phosphorus Homeostasis in Relation to Nutritional Intake in Very-Low-Birth-Weight Infants.

Authors:  Viola Christmann; Charlotte J W Gradussen; Michelle N Körnmann; Nel Roeleveld; Johannes B van Goudoever; Arno F J van Heijst
Journal:  Nutrients       Date:  2016-11-29       Impact factor: 5.717

6.  Growth and Bone Mineralization of Very Preterm Infants at Term Corrected Age in Relation to Different Nutritional Intakes in the Early Postnatal Period.

Authors:  Michelle N Körnmann; Viola Christmann; Charlotte J W Gradussen; Laura Rodwell; Martin Gotthardt; Johannes B Van Goudoever; Arno F J Van Heijst
Journal:  Nutrients       Date:  2017-12-02       Impact factor: 5.717

7.  Bone Mineral Density, Body Composition, and Metabolic Health of Very Low Birth Weight Infants Fed in Hospital Following Current Macronutrient Recommendations during the First 3 Years of Life.

Authors:  Walter Mihatsch; Izaskun Dorronsoro Martín; Vicente Barrios-Sabador; María L Couce; Gabriel Á Martos-Moreno; Jesús Argente; José Quero; Miguel Saenz de Pipaon
Journal:  Nutrients       Date:  2021-03-20       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.